Organic Active Ingredients TRIZ Cases

A topical vaginal gel formulation containing fertility aids and sodium hyaluronate to enhance sperm survival.

Cellular membrane-coated nanoparticles intercept pathogens by mimicking host cell adhesion, resolving limitations in conventional therapeutic targeting.

A dietary supplement composition containing phytosterols, omega-3 fatty acids, and coenzyme Q-10 reduces cholesterol levels.

A healing composition merges honey with extracellular matrix constituents to create a moist environment for skin repair.

Spherical nanoghost particles encapsulate pharmaceutical agents using isolated cell membranes.

Co-spray dried lactose and microcrystalline cellulose with povidone binder resolves stability and bioavailability issues in darunavir formulations.

Tertiary 8-hydroxyquinoline-7-carboxamide derivatives exhibit potent antifungal activity against diverse fungal pathogens.

PEG-BR/CWO nanoparticles convert X-ray energy into localized UV-A and blue light to activate bilirubin photosensitizers.

Formula I and II compounds inhibit beta-lactamase enzymes and efflux pumps to restore antibiotic potency against resistant pathogens.

A modified T-cell receptor uses specific amino acid substitutions to enhance binding specificity.

A Factor VIII composition uses histidine and calcium ions to stabilize the protein in aqueous solution.

Delta-tocotrienol targets cancer stem cell mechanisms to prevent recurrence while avoiding gastrointestinal toxicities of conventional chemoprevention agents.

A method adjusts mifepristone daily doses based on measured serum levels to maintain therapeutic concentrations.

PD-L1 inhibitors treat serrated colorectal cancer by targeting immunosuppressive microenvironments to overcome resistance.

Extracellular vesicles derived from red blood cells transport genetic material to target cells via electroporation.

Self-assembled oligofluorinated coatings prevent drug absorption into balloon materials, reducing systemic loss during localized delivery.

A combination of nicotinamide riboside and vitamin B12 modulates mitochondrial membrane potential to enhance hematopoietic stem cell function.

LNA oligomers delivered via liposomes inhibit HOXB-AS3 expression, improving survival in acute myeloid leukemia models without significant toxicity.

Peptidomimetic ligands activate Akt signaling in osteoprogenitor cells to stimulate bone mineralization and promote osteoblast activity.

Topical ruxolitinib cream addresses limited efficacy in vitiligo treatment by inhibiting inflammatory signals to achieve significant, durable repigmentation.

Segmented minitablets use pH-dependent and independent coatings to target nicotinamide and mesalazine release in the distal ileum and colon.

Double-stranded RNA oligonucleotides degrade ATN1 mRNA to reduce gene expression in brain regions.

Segmented holding teeth on an elastic cylinder provide uniform correcting force and pain-free attachment, eliminating skin irritation from adhesives.

pH-responsive polymer scaffold mediates controlled hydrogen sulfide release from biodegradable wound dressing, resolving cytotoxicity risks during angiogenesis.

A transdermal formulation combines glutathione with dimethyl sulfoxide and isopropyl myristate to enhance skin permeation.

Inhibiting Malassezia fungi with antifungal agents modulates the microbiome to enhance pancreatic ductal adenocarcinoma treatment efficacy.

Composite peptide mixtures with controlled charge ratios penetrate biofilms to kill embedded bacteria while minimizing cytotoxicity to human cells.

Solvent systems dissolve semi-solid cannabis distillate into oral films, eliminating thermal processing and enabling rapid buccal absorption.

Targeting the Polo-box domain avoids off-target kinase effects while improving intracellular permeability.

Stable bifunctional molecule salts recruit BTK to ubiquitin ligase for proteolytic degradation, overcoming C481S mutation resistance.

Segmenting yeast cell walls to isolate specific parietal polysaccharides resolves inconsistency in immune stimulation by targeting Dectin 1 receptors.

Segmented nicotine therapy offsets dopaminergic dyskinesias, reducing fall frequency and enhancing balance.

Segmented synthesis with preliminary protection improves esuberaprost prodrug stability and bioavailability for commercial viability.

Composite formulation of chlorogenic acid, vitamin C, and trace elements lowers total cholesterol and triglycerides without side effects.

Segmented CCR2 antagonists reduce macrophage-induced inflammation by blocking monocyte trafficking.

Magnesium aluminum silicate adsorbs metronidazole to mask bitter taste, resolving compliance issues without delaying absorption.

Direct compression of silodosin powder mixture with L-HPC bypasses wet granulation to improve content uniformity.

Administering a PC7 inhibitor reduces hepatic triglyceride levels through targeted molecular inhibition.

A three-layer backing structure stabilizes moisture in aqueous patches using a perforated film and fiber layers.

Segmented PEG-b-PLL nanoparticles protect siRNA from degradation and target CCK-B receptors on pancreatic cancer cells.

Inhibiting the ODC-driven pathway with DFMO restores immunotherapeutic efficacy in STK11-loss lung cancer by overcoming immune evasion mechanisms.

A quinolinone derivative inhibits TSLP and IL-33 binding to regulate intracellular signal transduction.

Optimized DPTIP structure delivers nanomolar potency and brain penetration, resolving low efficacy trade-offs in neurodegenerative disease treatment.

DLA and R1 combination mitigates microcirculation disorder symptoms by inhibiting leukocyte rolling, peroxide production, and plasma albumin leakage.

Enzyme-mediated glycosylation resolves cannabinoid hydrophobicity by attaching sugar moieties, enabling site-specific release via targeted tissue hydrolysis.

Triphenylacetate salts of rifamycin derivatives improve water solubility and chemical stability through controlled crystallization.

Elephant p53 protein sequences delivered via viral vectors overcome human p53 limitations by inducing apoptosis in mutated cells.

Deuterium substitution on the pyrimidopyrazolone core resists oxidative metabolism to extend half-life and improve bioavailability.

Soluble beta-glucan binds CR3 receptors on innate immune cells, shifting the tumor microenvironment from immunosuppressive to immunostimulatory states.

Polystyrene sulfonate intercepts the C3 complement activation loop to prevent hyper-inflammatory ocular tissue damage and vision loss.

Adding aronia polyphenols to milk chocolate reduces postprandial glucose spikes while maintaining consumer acceptance.

Specific lipid markers enable accurate Mycobacterium tuberculosis detection without cross-reactivity from BCG vaccination.

Enzastaurin upregulates FHIT and BMPR2 signaling to reverse pulmonary vasculopathy progression.

Amphiphilic neurosteroids target extrasynaptic NMDA receptors to block excitotoxic calcium influx while preserving normal synaptic signal transmission.

Optimized excipient composition ensures stable quality and bioavailability despite storage under extreme conditions.

Optimized acid hydrolysis yields soluble bioactive oligosaccharides, resolving the trade-off between solubility and manufacturing complexity.

A multilayer oral dosage form combines immediate and extended release components to deliver nalbuphine with controlled kinetics.

Segmenting patients by molecular subtype resolves the contradiction between prognostic simplicity and survival prediction accuracy.

Modified monosaccharides incorporate into cell membranes via metabolic pathways to enable precise eukaryotic cell detection.

Liposomes encapsulate fluticasone furoate via self-assembly, improving lung deposition while reducing side effects compared to dry powder inhalers.

Buffer systems control pH between 6 and 11 to prevent hydrolysis in aqueous clozapine suspensions.

Merges 5-fluorouracil and 5-hydroxymethyl-2′-deoxyuridine to resolve the contradiction between expanding treatment coverage and maintaining reliability.

Merges IAP and FLT3 inhibitors to overcome stromal-mediated resistance in acute myeloid leukemia.

Phosphoramidate prodrugs achieve selective hepatic uptake to inhibit HCV polymerase while minimizing gastrointestinal side effects.

Replacing mannitol with microcrystalline cellulose and sucrose simplifies manufacturing while maintaining dissolution and stability.

Albumin nanoparticles release 5-fluorouracil via diffusion to reduce pharmacokinetic variability and adverse effects.

Introducing a dimethylamino group to glaucocalyxin A resolves poor water solubility while preserving anti-tumor efficacy.

Dead Sea extract and tetrasaccharide polysaccharide form a physical skin barrier reducing ozone and heavy metal damage.

Hydration converts unstable anhydrous polymorphs into a stable monohydrate, resolving degradation resistance and solubility trade-offs.

2R-DDAIP increases drug absorption rates while maintaining skin stability and reducing irritation compared to racemic mixtures.

Substituted bicyclic compounds act as GPR40 agonists to manage Type 2 diabetes while reducing hypoglycemia risk.

DMSO selective extraction removes waxes and sugars without winterization, boosting CBD yield and purity while reducing THC below 0.3%.

Carbazole compounds inhibit androgen receptor signaling in prostate cancer cells.

Characterizing Centanafadine HCl Form CN1 via XRPD and NMR resolves contradictions between reliability and ease of manufacture.

Nanoscale droplet size stabilizes clobetasol propionate formulation while reducing ocular irritancy from high surfactant content.

Synthesizing 3-phenyl-2,8-dihydropyrano[2,3-f]chromene derivatives via coupling and cyclization reactions.

MHC II-targeted peptide-dendrimer nanoparticles reduce nephrotoxicity by delivering amphotericin B specifically to infected macrophages.

CXCR4 antagonists block CXCL12 signaling to disrupt the immunosuppressive barrier in HPV-associated tumors.

Combinations of purified kratom alkaloids and serotonergic agents optimize therapeutic profiles through controlled molar ratios.

A polycyclic cage-like heterocyclic hybrid compound inhibits cancer cell proliferation and induces apoptosis through multi-target engagement.

Oral plasma kallikrein inhibitor suppresses circulating enzyme levels, replacing injectable therapies that delay dosing and increase attack severity.

A novel small molecule uncoupler accelerates metabolic rate to reduce fat accumulation while preserving skeletal muscle mass.

A polymer-lipid microemulsion delivers antiviral drugs directly to lung tissue via a composite matrix structure.

Sodium stearyl fumarate lubricates brexpiprazole tablets to resolve manufacturing stability and dissolution contradictions.

15-PGDH inhibitors restore youthful tissue function by blocking enzyme degradation of prostaglandin E2.

Formula I bis-aryl amides block HGF binding to c-Met, preventing vascular hyperpermeability and tumor progression in malignancies.

A Hill coefficient threshold selects synergistic drug combinations from in vitro dose-response data.

Silica-based nanoparticles exploit macropinocytosis to bypass drug resistance in cancer stem cells, preventing tumor relapse.

Pharmaceutical composition replaces ethanol with propylene glycol and castor oil to prevent allergic reactions while maintaining fulvestrant solubility.

Formula I compounds inhibit neomorphic IDH activity, reducing R(-)-2-hydroxyglutarate production and treating glioma.

Pyrimidoisoquinolone compounds selectively inhibit TAM receptor family kinases to treat proliferative disorders like acute myeloid leukemia.

Heavy isotope substituted cytosine analogues exploit the kinetic isotope effect to modulate DNA methylation patterns.

Sulfonic acid salt functionalized porous beads remove cytokines and free hemoglobin to reduce transfusion adverse reactions.

Selective benzodiazepine derivatives target GABA A gamma1 receptors to restore inhibitory balance without sedation.

A sulfated hyperbranched polyester polyol derivative solubilizes hydrophobic drugs under aqueous conditions without organic solvents.